Accessed:

Bafetinib

Molecular formula:	C30H31F3N8O
Average mass:	576.627
Monoisotopic mass:	576.257292
ChemSpider ID:	9562515

1 of 1 defined stereocentres

Wikipedia

Structural identifiers

Names

Names and synonyms

Verified

859212-16-1

[RN]

Bafetinib

[Wiki]

[INN] [USAN]

bafétinib

[French]

[INN]

bafetinib

[Spanish]

[INN]

bafetinibum

[Latin]

[INN]

Benzamide, N-[3-([4,5′-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)-

[ACD/Index Name]

N-[3-(4,5′-Bipyrimidin-2-ylamino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl}-3-(trifluormethyl)benzamid

[German]

[ACD/IUPAC Name]

N-[3-(4,5′-Bipyrimidin-2-ylamino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl}-3-(trifluoromethyl)benzamide

[ACD/IUPAC Name]

N-[3-(4,5′-Bipyrimidin-2-ylamino)-4-méthylphényl]-4-{[(3S)-3-(diméthylamino)-1-pyrrolidinyl]méthyl}-3-(trifluorométhyl)benzamide

[French]

[ACD/IUPAC Name]

N-[3-({[4,5′-bipyrimidin]-2-yl}amino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide

NVW4Z03I9B

[UNII]

бафетиниб

[Russian]

[INN]

بافيتينيب

[Arabic]

[INN]

巴氟替尼

[Chinese]

[INN]

Unverified

(S)-N-(3-(4,5′-bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide

(S)-N-(3-([4,5′-bipyrimidin]-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide

4-(((3s)-3-dimethylaminopyrrolidin-1-yl)methyl)-n-(4-methyl-3-((4-pyrimidin-5-ylpyrimidin-2-yl)amino)phenyl)-3-(trifluoromethyl)benzamide

4-[[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide

4-[[(3S)-3-dimethylamino-1-pyrrolidinyl]methyl]-N-[4-methyl-3-[[4-(5-pyrimidinyl)-2-pyrimidinyl]amino]phenyl]-3-(trifluoromethyl)benzamide

4-[[(3S)-3-dimethylaminopyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide

4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-N-(4-methyl-3-{[4-(pyrimidin-5-yl)pyrimidin-2-yl]amino}phenyl)-3-(trifluoromethyl)benzamide

887650-05-7

[RN]

Bafetinib(INNO-406)

BCR_HUMAN

Breakpoint cluster region protein

carmustine;bcnu

Lyn-IN-1

LYN_HUMAN

MFCD11973647

[MDL number]

MFCD18633200

[MDL number]

N-(3-{[4,5′-bipyrimidine]-2-ylamino}-4-methylphenyl)-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide

N-[3-(4,5′-Bipyrimidin-2-Ylamino)-4-Methylphenyl]-4-{[(3s)-3-(Dimethylamino)pyrrolidin-1-Yl]methyl}-3-(Trifluoromethyl)benzamide

N-[3-([4,5′-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)-benzamide

N-[3-({[4,5′-bipyrimidine]-2-yl}amino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl)benzamide

Tyrosine-protein kinase Lyn

Database IDs